Literature DB >> 20424634

Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation.

David R Owen1, Owain W Howell, Sac-Pham Tang, Lisa A Wells, Idriss Bennacef, Mats Bergstrom, Roger N Gunn, Eugenii A Rabiner, Martin R Wilkins, Richard Reynolds, Paul M Matthews, Christine A Parker.   

Abstract

[(11)C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers. This phenomenon has not been reported for [(11)C]PK11195, another TSPO radioligand. We measured the specific binding signals with [(3)H]PK11195 and [(3)H]PBR28 in brain tissue from 22 donors. Overall, 23% of the samples did not generate a visually detectable specific autoradiographic signal with [(3)H]PBR28, although all samples showed [(3)H]PK11195 binding. There was a marked reduction in the affinity of [(3)H]PBR28 for TSPO in samples with no visible [(3)H]PBR28 autoradiographic signal (K(i)=188+/-15.6 nmol/L), relative to those showing normal signal (K(i)=3.4+/-0.5 nmol/L, P<0.001). Of this latter group, [(3)H]PBR28 bound with a two-site fit in 40% of cases, with affinities (K(i)) of 4.0+/-2.4 nmol/L (high-affinity site) and 313+/-77 nmol/L (low-affinity site). There was no difference in K(d) or B(max) for [(3)H]PK11195 in samples showing no [(3)H]PBR28 autoradiographic signal relative to those showing normal [(3)H]PBR28 autoradiographic signal. [(3)H]PK11195 bound with a single site for all samples. The existence of three different binding patterns with PBR28 (high-affinity binding (46%), low-affinity binding (23%), and two-site binding (31%)) suggests that a reduction in [(11)C]PBR28 binding may not be interpreted simply as a reduction in TSPO density. The functional significance of differences in binding characteristics warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20424634      PMCID: PMC2949260          DOI: 10.1038/jcbfm.2010.63

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  30 in total

1.  Labelling of peripheral-type benzodiazepine binding sites in human brain with [3H]PK 11195: anatomical and subcellular distribution.

Authors:  A Doble; C Malgouris; M Daniel; N Daniel; F Imbault; A Basbaum; A Uzan; C Guérémy; G Le Fur
Journal:  Brain Res Bull       Date:  1987-01       Impact factor: 4.077

2.  Binding of [3H]Ro 5-4864 and [3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites.

Authors:  M Awad; M Gavish
Journal:  J Neurochem       Date:  1987-11       Impact factor: 5.372

3.  Effects of temperature on the in vitro binding of 3H-raclopride to rat striatal dopamine-D2 receptors.

Authors:  H Hall; I Wedel; M Sallemark
Journal:  Pharmacol Toxicol       Date:  1988-08

4.  Structural and functional study of reconstituted peripheral benzodiazepine receptor.

Authors:  J J Lacapère; F Delavoie; H Li; G Péranzi; J Maccario; V Papadopoulos; B Vidic
Journal:  Biochem Biophys Res Commun       Date:  2001-06-08       Impact factor: 3.575

5.  In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion.

Authors:  A Cagnin; R Myers; R N Gunn; A D Lawrence; T Stevens; G W Kreutzberg; T Jones; R B Banati
Journal:  Brain       Date:  2001-10       Impact factor: 13.501

6.  Hormonal regulation of peripheral benzodiazepine receptor binding properties is mediated by subunit interaction.

Authors:  I Golani; A Weizman; S Leschiner; I Spanier; N Eckstein; R Limor; J Yanai; K Maaser; H Scherübl; G Weisinger; M Gavish
Journal:  Biochemistry       Date:  2001-08-28       Impact factor: 3.162

7.  Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker.

Authors:  William C Kreisl; Masahiro Fujita; Yota Fujimura; Nobuyo Kimura; Kimberly J Jenko; Pavitra Kannan; Jinsoo Hong; Cheryl L Morse; Sami S Zoghbi; Robert L Gladding; Steven Jacobson; Unsong Oh; Victor W Pike; Robert B Innis
Journal:  Neuroimage       Date:  2009-12-04       Impact factor: 6.556

8.  Design, synthesis and structure-affinity relationships of aryloxyanilide derivatives as novel peripheral benzodiazepine receptor ligands.

Authors:  Taketoshi Okubo; Ryoko Yoshikawa; Shigeyuki Chaki; Shigeru Okuyama; Atsuro Nakazato
Journal:  Bioorg Med Chem       Date:  2004-01-15       Impact factor: 3.641

9.  Differential binding properties of the peripheral-type benzodiazepine ligands [3H]PK 11195 and [3H]Ro 5-4864 in trout and mouse brain membranes.

Authors:  A J Eshleman; T F Murray
Journal:  J Neurochem       Date:  1989-08       Impact factor: 5.372

10.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.

Authors:  R B Banati; J Newcombe; R N Gunn; A Cagnin; F Turkheimer; F Heppner; G Price; F Wegner; G Giovannoni; D H Miller; G D Perkin; T Smith; A K Hewson; G Bydder; G W Kreutzberg; T Jones; M L Cuzner; R Myers
Journal:  Brain       Date:  2000-11       Impact factor: 13.501

View more
  101 in total

1.  (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.

Authors:  Eunkyung Park; Jean-Dominique Gallezot; Aracely Delgadillo; Shuang Liu; Beata Planeta; Shu-Fei Lin; Kevin C O'Connor; Keunpoong Lim; Jae-Yun Lee; Anne Chastre; Ming-Kai Chen; Nicholas Seneca; David Leppert; Yiyun Huang; Richard E Carson; Daniel Pelletier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-04-02       Impact factor: 9.236

2.  Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studies.

Authors:  Junchao Tong; Belinda Williams; Pablo M Rusjan; Romina Mizrahi; Jean-Jacques Lacapère; Tina McCluskey; Yoshiaki Furukawa; Mark Guttman; Lee-Cyn Ang; Isabelle Boileau; Jeffrey H Meyer; Stephen J Kish
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-20       Impact factor: 6.200

3.  Translocator protein PET imaging for glial activation in multiple sclerosis.

Authors:  Unsong Oh; Masahiro Fujita; Vasiliki N Ikonomidou; Iordanis E Evangelou; Eiji Matsuura; Erin Harberts; Yota Fujimura; Nancy D Richert; Joan Ohayon; Victor W Pike; Yi Zhang; Sami S Zoghbi; Robert B Innis; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-09-25       Impact factor: 4.147

Review 4.  Molecular imaging of microglia/macrophages in the brain.

Authors:  Sriram Venneti; Brian J Lopresti; Clayton A Wiley
Journal:  Glia       Date:  2012-05-21       Impact factor: 7.452

Review 5.  Imaging of atherosclerosis.

Authors:  D R J Owen; A C Lindsay; R P Choudhury; Z A Fayad
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

6.  Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography.

Authors:  Pablo M Rusjan; Alan A Wilson; Peter M Bloomfield; Irina Vitcu; Jeffrey H Meyer; Sylvain Houle; Romina Mizrahi
Journal:  J Cereb Blood Flow Metab       Date:  2011-04-27       Impact factor: 6.200

Review 7.  Roles of microglia in brain development, tissue maintenance and repair.

Authors:  Mackenzie A Michell-Robinson; Hanane Touil; Luke M Healy; David R Owen; Bryce A Durafourt; Amit Bar-Or; Jack P Antel; Craig S Moore
Journal:  Brain       Date:  2015-03-29       Impact factor: 13.501

8.  Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET study.

Authors:  Akihiro Takano; Balázs Gulyás; Andrea Varrone; Per Karlsson; Nils Sjoholm; Stig Larsson; Cathrine Jonsson; Richard Odh; Richard Sparks; Nabil Al Tawil; Anja Hoffmann; Torsten Zimmermann; Andrea Thiele; Christer Halldin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-06       Impact factor: 9.236

Review 9.  In vivo PET imaging of neuroinflammation in Alzheimer's disease.

Authors:  Julien Lagarde; Marie Sarazin; Michel Bottlaender
Journal:  J Neural Transm (Vienna)       Date:  2017-05-17       Impact factor: 3.575

10.  Synthesis and structure-activity relationships of 5,6,7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging.

Authors:  Dewei Tang; Eliot T McKinley; Matthew R Hight; Md Imam Uddin; Joel M Harp; Allie Fu; Michael L Nickels; Jason R Buck; H Charles Manning
Journal:  J Med Chem       Date:  2013-04-03       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.